These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3835613)

  • 41. [Phacoemulsification by the anterior approach combined with vitreoretinal surgery].
    Ullern M; Nicol JL; Ruellan YM; Boureau C; Morel C
    J Fr Ophtalmol; 1993; 16(5):320-4. PubMed ID: 8331252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy.
    Lewis H; Aaberg TM; Abrams GW
    Am J Ophthalmol; 1991 Jan; 111(1):8-14. PubMed ID: 1985496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The importance of silicone oil removal in prophylaxis of the late complications of internal tamponade].
    WesoĊ‚ek-Czernik A; Nawrocki J; Pikulski Z; Bogorodzki B
    Klin Oczna; 1998; 100(5):301-4. PubMed ID: 9884527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1.
    Arch Ophthalmol; 1992 Jun; 110(6):770-9. PubMed ID: 1596224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical treatments of proliferative vitreoretinopathy.
    Jalkh AE; Avila MP; Schepens CL; Azzolini C; Duncan JE; Trempe CL
    Arch Ophthalmol; 1984 Aug; 102(8):1135-9. PubMed ID: 6466173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A Review 20: Vitreo-retinal surgery].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2004 Oct; 108(10):623-39. PubMed ID: 15559316
    [No Abstract]   [Full Text] [Related]  

  • 47. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2.
    Arch Ophthalmol; 1992 Jun; 110(6):780-92. PubMed ID: 1596225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Peripheral retinectomy in proliferative vitreoretinopathy].
    Reinking U; Lucke K; Laqua H
    Fortschr Ophthalmol; 1990; 87(4):325-8. PubMed ID: 2210555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of massive vitreous retraction.
    Scott JD
    Trans Ophthalmol Soc U K (1962); 1975; 95(3):429-32. PubMed ID: 1066864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy.
    Glaser BM; Carter JB; Kuppermann BD; Michels RG
    Ophthalmology; 1991 Nov; 98(11):1613-21. PubMed ID: 1800921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Micro-vitreoretinal surgery for the treatment of complicated retinal detachment].
    Zhang SC; Gao RL
    Zhonghua Yan Ke Za Zhi; 1993 Jul; 29(4):202-4. PubMed ID: 8243187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined vitrectomy, intraocular microsurgery and liquid silicone in the treatment of proliferative vitreoretinopathy.
    Cairns JD; Anand N
    Aust J Ophthalmol; 1984 May; 12(2):133-8. PubMed ID: 6487183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe proliferative vitreoretinopathy and retinal detachment. I. Initial clinical findings.
    Ho PC; Yoshida A; Schepens CL; McMeel JW; Duncan JE
    Ophthalmology; 1984 Dec; 91(12):1531-7. PubMed ID: 6521991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of massive vitreous retraction.
    Scott JD
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):417-23. PubMed ID: 4602174
    [No Abstract]   [Full Text] [Related]  

  • 55. Scleral rupture during retinal detachment surgery: risk factors, management options, and outcomes.
    Tabandeh H; Flaxel C; Sullivan PM; Leaver PK; Flynn HW; Schiffman J
    Ophthalmology; 2000 May; 107(5):848-52. PubMed ID: 10811073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of complicated retinal detachment with proliferative vitreoretinopathy.
    Zivojnovic R; Claes C
    Bull Soc Belge Ophtalmol; 1990; 235():65-9. PubMed ID: 2129934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Results of silicone oil injections in various stages of proliferative vitreoretinopathy].
    Tavakolian U; Wollensak J
    Klin Monbl Augenheilkd; 1985 Apr; 186(4):268-71. PubMed ID: 3999611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment.
    Bonnet M
    Ophthalmologica; 1984; 188(3):148-52. PubMed ID: 6538676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The outcomes of scleral buckling versus re-vitrectomy for the treatment of recurrent inferior retinal detachment in silicone oil tamponade eyes.
    Wei Y; Wu G; Xu K; Wang J; Zu Z; Wang R
    Acta Ophthalmol; 2016 Nov; 94(7):e624-e628. PubMed ID: 27061348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of silicone oil removal. Silicone Study Report 6.
    Hutton WL; Azen SP; Blumenkranz MS; Lai MY; McCuen BW; Han DP; Flynn HW; Ramsay RC; Ryan SJ
    Arch Ophthalmol; 1994 Jun; 112(6):778-85. PubMed ID: 8002836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.